Skip to content
ETopical – Lifestyle
Author:
4Bio Capital
4BIO Capital leads €40 Million ($45M) seed financing of Aptadir Therapeutics to advance first-in-class demethylating medicines
September 29, 2026
4BIO Capital Leads $33M Seed for Cloverleaf Bio’s RNA Cancer Therapeutics
September 8, 2026
4BIO Capital leads oversubscribed £61 million ($83m) Series A financing of Cytospire Therapeutics
May 5, 2026
4BIO Capital portfolio company Ray Therapeutics announces upsized and oversubscribed $125 Million Series B financing for vision restoration treatments
April 21, 2026